Cases of rare blood clots identified after AstraZeneca Covid-19 jabs

Sunday, 04 Apr, 2021

The MHRA previously said there had been 30 cases of rare blood clot events reported out of the 18.1 million AstraZeneca/Oxford vaccine doses administered in Britain. They involve blood clots combined with unusually low levels of platelets, a disorder that can lead to heavy bleeding.

Several European countries temporarily suspended their use of the vaccine after a small number of people developed blood clots, but most restarted after the EU medicines regulator concluded it was safe and effective.

However, he said the risks of taking the AstraZeneca vaccine are still far outweighed by the risks of not getting the jab.

However, the regulator said that the benefits of coronavirus vaccines outweigh any risks and people should continue to get inoculated.

But the Australian Technical Advisory Group on Immunisation (ATAGI) and the Therapeutic Goods Administration (TGA) did not recommend changes to the vaccine rollout, acting chief medical officer Michael Kidd said on Saturday.

The Netherlands was the lastest European countries to stop using the AstraZeneca vaccine to vaccinate people under the age of 60, amid fears of a link between it and the incidence of rare blood clots.

He said the reported side effects were treatable allergies and there was no evidence that the vaccine causes adverse effects or death.

Germany took a similar decision earlier this week. The EMA is expected to announce updated advice on the issue on April 7.

The woman had a lung embolism and a cerebral haemorrhage, Lareb said.

This figure did not include all Germany's cases, however.

An AFP tally shows the region reaching the grim milestone of 25 107 991 infections, putting it in third place after Europe, with more than 44.4 million cases, and the United States and Canada with almost 31.6 million.

In November, the United Kingdom became the first Western country to approve a coronavirus vaccine.

A spokeswoman for AstraZeneca told AFP that patient safety is its "highest priority".

"My general feeling is that given the contractual relationships that we have with a number of companies, that we have enough vaccine to fulfill all of our needs without invoking AstraZeneca,"Fauci said. One died and one also had a brain haemorrhage", it said".

Pharmacist Mario Linaksita, right, administers the AstraZeneca Covid-19 vaccine to Sharon Berringer, 56, at University Pharmacy, in Vancouver, British Columbia. It also ordered 30 million doses of the Pfizer-BioNTech vaccine the same year.